سعر تارجوماش 80مجم 30 قرص 2025

Valsartan 80 mg film-coated tablets, 30 tablets (3 strips), by Mash Premiere (Egypt); angiotensin II receptor blocker.

• Hypertension, to lower blood pressure.Population: Adults and children 1 year and olderDailyMed (U.S. National Library of Medicine)
• Heart failure (NYHA II-IV), to reduce hospitalization for heart failure.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Post-myocardial infarction with left ventricular failure/dysfunction, to reduce cardiovascular mortality.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Hypertension: headache, dizziness, viral infection, fatigue, abdominal pain. Heart failure: dizziness, hypotension, diarrhea, arthralgia, back pain, fatigue, hyperkalemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Do not coadminister aliskiren in patients with diabetes.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning (fetal toxicity): drugs acting on the renin-angiotensin system can cause fetal injury and death; discontinue as soon as pregnancy is detected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypotension in volume- or salt-depleted patients; monitor renal function and serum potassium in susceptible patients.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Potassium-sparing diuretics, potassium supplements, potassium salt substitutes, heparinIncreased serum potassium (and creatinine in heart failure); monitor potassium.DailyMed (U.S. National Library of Medicine)
• NSAIDs including COX-2 inhibitorsRisk of renal function deterioration and reduced antihypertensive effect.DailyMed (U.S. National Library of Medicine)
• LithiumIncreased serum lithium and lithium toxicity; monitor lithium levels.DailyMed (U.S. National Library of Medicine)

• Use of RAS-acting drugs in the second and third trimesters reduces fetal renal function and increases fetal and neonatal morbidity and death; oligohydramnios reported with valsartan.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No human data; valsartan is present in rat milk; breastfeeding is not recommended during treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Valsartan: Blocks binding of angiotensin II to the AT1 receptor, inhibiting its vasoconstrictor and aldosterone-secreting effects.